Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study
Autor: | Andrea Airoldi, Maurizio Rizzi, Pierachille Santus, Marica Pecis, Elisa Franceschi, Dejan Radovanovic, Stefano Pini |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
CRP
C reactive protein Male Pediatrics WBC white blood cells Respiratory failure 0302 clinical medicine PaO2 peripheral arterial oxygen partial pressure Hospital Mortality Prospective Studies 030212 general & internal medicine LMWH Low Molecular Weight Heparin Prospective cohort study CPAP Continuous Positive Airway Pressure Respiratory distress Lopinavir Middle Aged Hospitalization Survival Rate Italy Methylprednisolone COVID-19 Coronavirus Disease 2019 ED emergency department Female FiO2 inspired oxygen fraction Seasons medicine.drug Adult Pulmonary and Respiratory Medicine Respiratory Therapy medicine.medical_specialty Short Communication DNI do not intubate order Antiviral Agents HDRU high dependency respiratory unit 03 medical and health sciences CPAP PaCO2 peripheral arterial carbon dioxide partial pressure medicine Humans Mortality Survival rate Aged LDH lactic acid dehydrogenase business.industry COVID-19 Anticoagulants Hydroxychloroquine Pneumonia Length of Stay medicine.disease Treatment FEU fibrinogen equivalent unit IMV invasive mechanical ventilation 030228 respiratory system PEEP positive end expiratory pressure SaO2 peripheral oxygen saturation business Hb hemoglobin |
Zdroj: | Respiratory Medicine |
ISSN: | 0954-6111 |
DOI: | 10.1016/j.rmed.2021.106323 |
Popis: | Background The therapeutic approach to COVID-19 and healthcare system preparedness improved during 2020. We compared characteristics and outcomes of hospitalized COVID-19 patients during the first 28 days of the March and October pandemic waves in Milan, Italy. Material and methods A prospective, observational study enrolling adult patients hospitalized with COVID-19 pneumonia during March 7-April 4 (1st period) and October 15-November 12 (2nd period). During the 1st period hydroxychloroquine, lopinavir/ritonavir and therapeutic enoxaparin when thrombosis was confirmed were administered; systemic corticosteroids were given in case of severe pneumonia. During the 2nd period dexamethasone, methylprednisolone, remdesivir, thromboprophylaxis or anticoagulation were administered according to international recommendations. Patients with respiratory distress on oxygen masks initiated CPAP. Outcomes were: length of hospital stay, all-cause in-hospital mortality and need for intubation. Results We included 70 patients (75% males) during the 1st and 76 patients (51% males, p = 0.522) during the 2nd period. Prevalence of severe respiratory failure (30% vs. 12%, p = 0.006), and D-dimer >3000 FEU (34% vs. 15%, P = 0.012) were reduced during the 2nd period, while anticoagulation and corticosteroids were more frequently administered (both p Highlights • We compared patients' characteristics and outcomes during the 2020 1st and 2nd epidemic waves in Milan. • The proportion of patients with severe respiratory failure was higher during the 1st period. • Timing of referral and all-cause mortality were significantly decreased during the 2nd period. • Higher social awareness and change in treatment regimens may have promoted better outcomes during the 2nd pandemic wave. |
Databáze: | OpenAIRE |
Externí odkaz: |